Local inhibition of natural killer cell activity promotes the progressive growth of intraocular tumors

Investigative Ophthalmology and Visual Science

Volumn 38, Issue 6, 1997, Pages 1277-1282

  Apte, Rajendra S ^a   Mayhew, Elizabeth ^a   Niederkorn, Jerry Y ^a,b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

anterior chamber; aqueous humor; natural killer; ocular melanoma

Indexed keywords

ANTIBODY; GANGLIOTETRAOSYLCERAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS HUMOR; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; INTRAOCULAR TUMOR; LYMPHOMA; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RABBIT; TUMOR CELL LINE; TUMOR GROWTH; UVEA MELANOMA;

ANIMALS; AQUEOUS HUMOR; CELL DIVISION; CYTOTOXINS; DISEASE PROGRESSION; EYE; EYE NEOPLASMS; GRAFT REJECTION; INJECTIONS; INJECTIONS, SUBCUTANEOUS; KILLER CELLS, NATURAL; MICE; MICE, INBRED BALB C; MICE, SCID; NEOPLASM TRANSPLANTATION; RABBITS; TUMOR CELLS, CULTURED;

EID: 0030988168     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Niederkorn JY. Immune privilege and immune regulation in the eye. Adv Immunol. 1990;48:191-226.
2. Streilein JW. Immune privilege of local tissue barriers and immunosuppressive microenvironments. Curr Opin Immunol. 1993;5:428-432.
3. Ljunggren H, Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today. 1990;11:237-244.
4. Ma D, Luyten GP, Luider TM, Niederkorn JY. Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model. Invest Ophthalmol Vis Sci. 1995;36:435-441.
5. Karre K, Ljunggren HG, Piontek G, Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy. Nature. 1986;319:675-678.
6. Apte RS, Niederkorn JY. Isolation and characterization of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye. J Immunol. 1996;156:2667-2673.
7. Niederkorn JY, Knisely TL, Mayhew E. Immune rejection of metastases arising from intraocular tumors in mice. Invest Ophthalmol Vis Sci 1986;27:1355-1360.
8. Griffith TS, Brunner T, Fletcher SM, et al. Fas Ligand- induced apoptosis as a mechanism of Immune Privilege. Science. 1995;270:1189-1192.
9. Jager JM, Blom DJ, Zwinderman AH, Luyten GPM, Kerkvliet S, Mooy CM. HLA class I expression and prognosis in uveal melanomas. JERMOV Abstracts. Vision Res. 1996;36:S124.
10. Natali PG, Bigotti A, Nicotra MR, et al. Analysis of antigenic profile of uveal melanoma lesions with anticutaneous melanoma associated antigen and anti- HLA monoclonal antibody. Cancer Res. 1989;49:1269- 1274.